DK0442850T3 - Estere af acyl L-carnitiner med gamma-hydroxysmørsyre samt farmaceutiske præparater indeholdende disse til hæmning af neurondegeneration og til behandling af coma - Google Patents
Estere af acyl L-carnitiner med gamma-hydroxysmørsyre samt farmaceutiske præparater indeholdende disse til hæmning af neurondegeneration og til behandling af comaInfo
- Publication number
- DK0442850T3 DK0442850T3 DK91830024.5T DK91830024T DK0442850T3 DK 0442850 T3 DK0442850 T3 DK 0442850T3 DK 91830024 T DK91830024 T DK 91830024T DK 0442850 T3 DK0442850 T3 DK 0442850T3
- Authority
- DK
- Denmark
- Prior art keywords
- acid
- carnitines
- coma
- esters
- acyl
- Prior art date
Links
- -1 acyl L-carnitines Chemical class 0.000 title abstract 5
- SJZRECIVHVDYJC-UHFFFAOYSA-N 4-hydroxybutyric acid Chemical compound OCCCC(O)=O SJZRECIVHVDYJC-UHFFFAOYSA-N 0.000 title abstract 2
- 206010010071 Coma Diseases 0.000 title abstract 2
- 150000002148 esters Chemical class 0.000 title abstract 2
- 230000002401 inhibitory effect Effects 0.000 title abstract 2
- 230000004770 neurodegeneration Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 7
- 150000003839 salts Chemical class 0.000 abstract 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 abstract 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 abstract 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 206010039966 Senile dementia Diseases 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 150000001450 anions Chemical class 0.000 abstract 1
- 229940009098 aspartate Drugs 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 abstract 1
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/20—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C219/22—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT47618A IT1240760B (it) | 1990-02-12 | 1990-02-12 | Esteri di acil-l-carnitine con l'acido gamma-idrossibutirrico e composizioni farmaceutiche che li contengono per l'inibizione della degenerazione neuronale e nel trattamento del coma. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0442850T3 true DK0442850T3 (da) | 1994-09-05 |
Family
ID=11261466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK91830024.5T DK0442850T3 (da) | 1990-02-12 | 1991-01-28 | Estere af acyl L-carnitiner med gamma-hydroxysmørsyre samt farmaceutiske præparater indeholdende disse til hæmning af neurondegeneration og til behandling af coma |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US5543556A (da) |
| EP (1) | EP0442850B1 (da) |
| JP (1) | JP2930749B2 (da) |
| AT (1) | ATE109128T1 (da) |
| DE (1) | DE69103037T2 (da) |
| DK (1) | DK0442850T3 (da) |
| ES (1) | ES2057837T3 (da) |
| IT (1) | IT1240760B (da) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1242020B (it) * | 1990-11-20 | 1994-02-02 | Sigma Tau Ind Farmaceuti | Ftalidilidene derivati della carnitina e di alcanoil carnitine e composizioni farmaceutiche che li contengono. |
| IT1244636B (it) * | 1991-01-04 | 1994-08-08 | Sigma Tau Ind Farmaceuti | Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento. |
| IT1248321B (it) * | 1991-05-15 | 1995-01-05 | Sigma Tau Ind Farmaceuti | Uso di esteri di acil l-carnitine con l'acido gamma-idrossibutirrico per produrre composizioni farmaceutiche per il trattamento di epatopatie |
| IT1263013B (it) * | 1992-10-20 | 1996-07-23 | Avantgarde Spa | Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee. |
| IT1261432B (it) * | 1993-03-26 | 1996-05-23 | Sigma Tau Ind Farmaceuti | Uso di acil l- carnitina gammaidrossibutirrato per il trattamento dell'alcolismo. |
| IT1261984B (it) * | 1993-06-22 | 1996-06-11 | Avantgarde Spa | Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee. |
| IT1261828B (it) * | 1993-07-14 | 1996-06-03 | Sigma Tau Ind Farmaceuti | Esteri di acil l-carnitine e composizioni farmaceutiche che li contengono per il trattamento dello shock endotossico. |
| IT1276225B1 (it) * | 1995-10-17 | 1997-10-27 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per |
| IT1276253B1 (it) | 1995-12-15 | 1997-10-27 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi |
| IT1291113B1 (it) * | 1997-03-20 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizione nutritiva terapeutica per soggetti affetti da diabete mellito |
| US6090848A (en) * | 1997-12-01 | 2000-07-18 | Sigma-Tau Healthscience S.P.A. | Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans |
| US5863940A (en) | 1997-12-01 | 1999-01-26 | Sigma-Tau Healthscience S.P.A. | Medicament and therapeutical method for treating idiopathic asthenozoospermia |
| DE69820029T3 (de) | 1998-03-19 | 2011-05-19 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Kombinierte Zusammensetzung bestehend aus L-Karnitin oder L-Alkanoylkarnitin, einem Glycosaminoglycan und/oder einem seiner Bestandteile |
| US7015200B2 (en) | 2000-09-22 | 2006-03-21 | Orphan Medical, Inc. | Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| WO2012069221A1 (en) | 2010-11-22 | 2012-05-31 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Therapeutical method for the treatment of the leber optic |
| US20140294921A1 (en) | 2010-12-09 | 2014-10-02 | Sigma-Tau Industrie Famaceutiche Riunite S.P.A. | Composition for tipical use for treating skin disorders |
| EP2783695A1 (en) | 2013-03-28 | 2014-10-01 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Physiological supplement or medicament for ophthalmic use containing L-carnitine or alkanoyl L-carnitines in combination with eledoisin |
| EP4585270A3 (en) | 2016-06-07 | 2025-09-24 | The J. David Gladstone Institutes | Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compositions and methods for using same |
| EP3654963A4 (en) | 2017-07-21 | 2021-04-14 | Buck Institute for Research on Aging | BETA-HYDROXYBUTYRATE AND BUTANEDIOL S ENANTIOMERS AND THEIR METHODS OF USE |
| US12037317B2 (en) | 2018-01-25 | 2024-07-16 | Buck Institute For Research On Aging | Synthesis of 3-hydroxybutyryl 3-hydroxybutyrate and related compounds |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4032641A (en) * | 1976-06-09 | 1977-06-28 | Tanabe Seiyaku Co., Ltd. | Nicotinoyl carnitine derivatives |
| AU518617B2 (en) * | 1977-04-29 | 1981-10-08 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Therapeutic application of acetyl-d, 1-carnitine |
| IT1116037B (it) * | 1979-04-23 | 1986-02-10 | Sigma Tau Ind Farmaceuti | Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico |
| IT1177874B (it) * | 1984-07-04 | 1987-08-26 | Sigma Tau Ind Farmaceuti | Estere della acetil carnitina,procedimenti per la sua preparazione e composizioni farmaceutiche che lo contengono |
| IT1231751B (it) * | 1989-04-12 | 1991-12-21 | Sigma Tau Ind Farmaceuti | Procedimento per la produzione di r(+) amminocarnitina e s(-) amminocarnitina |
| IT1256705B (it) * | 1992-12-21 | 1995-12-12 | Sigma Tau Ind Farmaceuti | Procedimento per la preparazione di l-(-)-carnitina a partire da un prodotto di scarto avente opposta configurazione. |
-
1990
- 1990-02-12 IT IT47618A patent/IT1240760B/it active IP Right Grant
-
1991
- 1991-01-28 DK DK91830024.5T patent/DK0442850T3/da active
- 1991-01-28 DE DE69103037T patent/DE69103037T2/de not_active Expired - Fee Related
- 1991-01-28 ES ES91830024T patent/ES2057837T3/es not_active Expired - Lifetime
- 1991-01-28 EP EP91830024A patent/EP0442850B1/en not_active Expired - Lifetime
- 1991-01-28 AT AT91830024T patent/ATE109128T1/de not_active IP Right Cessation
- 1991-02-08 JP JP3039174A patent/JP2930749B2/ja not_active Expired - Fee Related
-
1994
- 1994-10-04 US US08/317,750 patent/US5543556A/en not_active Expired - Fee Related
-
1995
- 1995-02-28 US US08/395,914 patent/US5534549A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE109128T1 (de) | 1994-08-15 |
| US5543556A (en) | 1996-08-06 |
| DE69103037T2 (de) | 1994-11-17 |
| IT1240760B (it) | 1993-12-17 |
| IT9047618A1 (it) | 1991-08-13 |
| EP0442850A1 (en) | 1991-08-21 |
| ES2057837T3 (es) | 1994-10-16 |
| HK1005859A1 (en) | 1999-01-29 |
| US5534549A (en) | 1996-07-09 |
| JP2930749B2 (ja) | 1999-08-03 |
| EP0442850B1 (en) | 1994-07-27 |
| DE69103037D1 (de) | 1994-09-01 |
| IT9047618A0 (it) | 1990-02-12 |
| JPH06179642A (ja) | 1994-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0442850T3 (da) | Estere af acyl L-carnitiner med gamma-hydroxysmørsyre samt farmaceutiske præparater indeholdende disse til hæmning af neurondegeneration og til behandling af coma | |
| DK0443996T3 (da) | Estere af (R)(-)-carnitin og acyl (R)(-)-carnitiner med beta-hydroxysmørsyre og farmaceutiske præparater indeholdende disse til inhibering af neurondegeneration og leverproteolyse samt til behandling af coma | |
| DK0429403T3 (da) | Ester af L-carnitin med gamma-hydroxysmørsyre samt farmaceutiske præparater indeholdende denne til inhibering af neurondegeneration og til behandling af coma | |
| ES8601856A1 (es) | Un procedimiento para producir sales no hogroscopicas de l-carnitina y de alcanoil-l-carnitina | |
| DK0514359T3 (da) | Alkanoyl-L-carnitin-amider med aminosyrer og farmaceutiske præparater indeholdende disse til fremme af regeneration af nervevæv, inhibering af neuronal degeneration, forøgelse af indlærings- og hukommelsesprocesserne og behandling af coma | |
| EP0290819A3 (en) | Pteridines suitable for the preparation of pharmaceutical compositions with antiamnesic activity | |
| DE69305540D1 (de) | Ester des Acyl-Carnitins mit langkettigen aliphatischen Alkoholen und diese enthaltende pharmazeutische Zusammensetzungen mit antibakterieller Wirkung | |
| DE69207479T2 (de) | Verwendung der Ester von Acyl-L-Carnitin mit Gamma-Hydroxy-Buttersäure zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Lebererkrankungen | |
| HK1005848B (en) | Use of esters of acyl l-carnitines with gamma-hydroxybutyric acid for producing pharmaceutical compositions for the treatment of hepatopathies | |
| ATE253823T1 (de) | Verwendung von quaternären carbonsäurealkanolaminestersalzen als mikrobizide wirkstoffe | |
| KR940006576A (ko) | 에이즈 및 에이즈 관련 증후군 환자 및 무증후성 hiv혈청양성 환자치료를 위한 l-카르니틴 및 아실 l-카르니틴의 용도 | |
| HUT61993A (en) | Process for producing new imidazolylmethylpyridyl derivatives and pharmaceutical compositions comprising same as active ingredient | |
| IE882538L (en) | Oximes of tetrahydropyridine-3-carboxaldehyde | |
| HUT62303A (en) | Process for producing n-substituted aminomethane diphosphonic acids and pharmaceutical compositions comprising same as active ingredient | |
| DE69410866D1 (de) | Verwendung von Ester von Acyl-L-Carnitin mit Gammahydroxybuttersäure zur Behandlung von Alkoholismus | |
| HK1005859B (en) | Esters of acyl l-carnitines with gamma-hydroxybutyric acid and pharmaceutical compositions containing them for inhibiting neuronal degeneration and for the treatment of coma |